FDA Inspection 1077758 — South Texas Blood and Tissue Center

South Texas Blood and Tissue Center — FEI 3007003817

The FDA completed an inspection of South Texas Blood and Tissue Center on January 18, 2019 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 18, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
San Antonio, TX (United States)